Publications by authors named "Gerd Sutter"

Claim this Profile
S
Strong immunogenicity and protection against SARS-CoV-2 in hamsters induced by heterologous boost vaccination with an MVA-based COVID-19 vaccine candidate.
Sonja Ohrnberger, Christian Meyer Zu Natrup, Sabrina Clever, Lisa-Marie Schünemann, Federico Armando, Gerd Sutter

J Gen Virol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust polyfunctional CD8 and CD4 T cell responses in HLA-A*0201/DR1 transgenic mice following vaccination with modified vaccinia virus Ankara-based vaccines delivering Lassa virus glycoprotein or nucleoprotein.
Alina Tscherne, Georgia Kalodimou, Sylvia Jany, Astrid Freudenstein, Satendra Kumar, Gerd Sutter

J Gen Virol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of emergency maternal MVA-ZIKV vaccination in a rapid challenge model of lethal Zika infection.
Asisa Volz, Sabrina Clever, Alina Tscherne, Astrid Freudenstein, Sylvia Jany, Gerd Sutter

NPJ Vaccines· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and evaluation of a poly-epitope based vaccine for the induction of influenza A virus cross-reactive CD8 + T cell responses.
Sharmistha Dam, Alina Tscherne, Leoni Engels, Gerd Sutter, Albert D M E Osterhaus

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial.
Matthijs P Raadsen, Christine Dahlke, Anahita Fathi, Svenja Hardtke, Michael Klüver, Gerd Sutter

Lancet Infect Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Brighton collaboration standardized template with key considerations for a benefit/risk assessment for a viral vector vaccine based on a non-replicating modified vaccinia virus Ankara viral vector.
Ellen K Link, Alina Tscherne, Gerd Sutter, Emily R Smith, Marc Gurwith

Vaccine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans.
Alina Tscherne, Georgia Kalodimou, Alexandra Kupke, Cornelius Rohde, Astrid Freudenstein, Gerd Sutter

Vaccines (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study.
Satendra Kumar, Liangliang Nan, Georgia Kalodimou, Sylvia Jany, Astrid Freudenstein, Gerd Sutter

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a Spike-Specific CD8+ T-Cell Epitope Following Vaccination Against the Middle East Respiratory Syndrome Coronavirus in Humans.
Caroline E Harrer, Leonie Mayer, Anahita Fathi, Susan Lassen, My L Ly, Gerd Sutter

J Infect Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics characterization of the monkeypox virus infection.
Yiqi Huang, Valter Bergant, Vincent Grass, Quirin Emslander, M Sabri Hamad, Gerd Sutter

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach.
Leonie M Weskamm, Paulina Tarnow, Charlotte Harms, Melanie Huchon, Matthijs P Raadsen, Gerd Sutter

iScience· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses.
Juan J Rojas, Lien Van Hoecke, Miquel Conesa, Carmen Bueno-Merino, Ana Del Canizo, Gerd Sutter

Mol Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection.
Sabrina Clever, Leonard Limpinsel, Christian Meyer Zu Natrup, Lisa-Marie Schünemann, Georg Beythien, Gerd Sutter

Viruses· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective MVA-ST Vaccination Robustly Activates T Cells and Antibodies in an Aged-Hamster Model for COVID-19.
Sabrina Clever, Lisa-Marie Schünemann, Federico Armando, Christian Meyer Zu Natrup, Tamara Tuchel, Gerd Sutter

Vaccines (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection.
Mareike Kubinski, Jana Beicht, Thomas Gerlach, Amare Aregay, Albert D M E Osterhaus, Gerd Sutter

Vaccines (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans.
Leonie Mayer, Leonie M Weskamm, Anahita Fathi, Maya Kono, Jasmin Heidepriem, Gerd Sutter

NPJ Vaccines· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice.
Kim Thi Hoang Do, Stefanie Willenzon, Jasmin Ristenpart, Anika Janssen, Asisa Volz, Gerd Sutter

Front Cell Infect Microbiol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease.
Stephanie Riederer, Ana Del Canizo, Javier Navas, Marlowe G Peter, Ellen K Link, Gerd Sutter

Cancer Gene Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice.
Jana Beicht, Mareike Kubinski, Isabel Zdora, Christina Puff, Jeannine Biermann, Gerd Sutter

Front Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination.
Christian Meyer Zu Natrup, Lisa-Marie Schünemann, Giulietta Saletti, Sabrina Clever, Vanessa Herder, Gerd Sutter

Emerg Infect Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice.
Martin C Langenmayer, Anna-Theresa Luelf-Averhoff, Lisa Marr, Sylvia Jany, Astrid Freudenstein, Gerd Sutter

Pathogens· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection.
Mareike Kubinski, Jana Beicht, Isabel Zdora, Jeannine Biermann, Christina Puff, Gerd Sutter

Front Immunol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short- and Long-Interval Prime-Boost Vaccination with the Candidate Vaccines MVA-SARS-2-ST and MVA-SARS-2-S Induces Comparable Humoral and Cell-Mediated Immunity in Mice.
Georgia Kalodimou, Sylvia Jany, Astrid Freudenstein, Jan Hendrik Schwarz, Leonard Limpinsel, Gerd Sutter

Viruses· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251.
Jeffy G Mattathil, Asisa Volz, Olusegun O Onabajo, Sean Maynard, Sandra L Bixler, Gerd Sutter

Nat Commun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice.
Lucas Wilken, Sonja Stelz, Ayse Agac, Gerd Sutter, Chittappen Kandiyil Prajeeth

Vaccines (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis